Cha Vaccine Research Institute Co., Ltd. announced a private placement to issue Series 4 Bearer-bearing interest-bearing, unsecured private convertible bonds for the gross proceeds of KRW 10,000,000,000 on November 15, 2023. The transaction will include participation from new investors Samsung Securities Co., Ltd. for KRW 3,600,000,000, Samsung Securities Co., Ltd. for KRW 1,300,000,000, KB Securities Co., Ltd. for KRW 1,000,000,000, NH Investment & Securities Co., Ltd. for KRW 1,000,000,000, KB Securities Co., Ltd. for KRW 800,000,000, NH Investment & Securities Co., Ltd. for KRW 300,000,000, Mirae Asset Securities Co., Ltd. for KRW 1,000,000,000 and EBEST Investment & Securities Co., Ltd. for KRW 1,000,000,000. The transaction has been approved by the shareholders of the company and is expected to close on November 17, 2023.

The bonds bear zero coupon rate and 3% maturity and matures on November 17, 2028. The bonds are 100% convertible into 1,828,153 shares at a fixed conversion price of KRW 5,470 from November 17, 2024 to October 17, 2028. The securities are restricted to a hold period.